Sarah Rosli

722 total citations
19 papers, 513 citations indexed

About

Sarah Rosli is a scholar working on Molecular Biology, Immunology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Sarah Rosli has authored 19 papers receiving a total of 513 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Immunology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Sarah Rosli's work include Inflammasome and immune disorders (8 papers), Cardiovascular Function and Risk Factors (4 papers) and Immune Response and Inflammation (4 papers). Sarah Rosli is often cited by papers focused on Inflammasome and immune disorders (8 papers), Cardiovascular Function and Risk Factors (4 papers) and Immune Response and Inflammation (4 papers). Sarah Rosli collaborates with scholars based in Australia, United States and United Kingdom. Sarah Rosli's co-authors include Rebecca H. Ritchie, Cheng Xue Qin, Michelle D. Tate, Ashley Mansell, Helen Kiriazis, Xiao‐Jun Du, Kate E. Lawlor, Miles J. De Blasio, Julie R. McMullen and Minh Deo and has published in prestigious journals such as Circulation, Nature Communications and The Journal of Immunology.

In The Last Decade

Sarah Rosli

19 papers receiving 510 citations

Peers

Sarah Rosli

IMMUN

CCM

SURGE

EPIDE

Yiguo Qiu China

Jinyu Chi China

Yajuan Zhu China

Zhaohua Cai China

Leticia González Chile

Munehiko Shibata Japan

Susanna Fiorelli Italy

Kenneth E. Bernstein United States

Caitlin Lewis United States

Yiguo Qiu China

Sarah Rosli

241 ×0.8

182 ×1.3

IMMUN

89 ×0.7

CCM

70 ×1.0

SURGE

66 ×1.0

EPIDE

Citations per year, relative to Sarah Rosli Sarah Rosli (= 1×) peers Yiguo Qiu

Countries citing papers authored by Sarah Rosli

Since Specialization

Citations

This map shows the geographic impact of Sarah Rosli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Rosli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Rosli more than expected).

Fields of papers citing papers by Sarah Rosli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Rosli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Rosli. The network helps show where Sarah Rosli may publish in the future.

Co-authorship network of co-authors of Sarah Rosli

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Rosli. A scholar is included among the top collaborators of Sarah Rosli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Rosli. Sarah Rosli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Rosli, Sarah, Rebecca L Ambrose, Christopher M. Harpur, et al.. (2025). Gasdermin E deficiency limits inflammation and lung damage during influenza virus infection. Cell Death and Disease. 16(1). 440–440. 1 indexed citations

Lam, Maggie, Christopher Hodges, Christopher M. Harpur, et al.. (2025). NLRP3 deficiency abrogates silica-induced neutrophil infiltration, pulmonary damage and fibrosis. Respiratory Research. 26(1). 109–109. 4 indexed citations

Rosli, Sarah, Maggie Lam, Roland E. Dolle, et al.. (2023). A novel dual NLRP1 and NLRP3 inflammasome inhibitor for the treatment of inflammatory diseases. Clinical & Translational Immunology. 12(6). e1455–e1455. 29 indexed citations

Rosli, Sarah, Linden J. Gearing, Jodee A. Gould, et al.. (2023). Constitutive expression and distinct properties of IFN-epsilon protect the female reproductive tract from Zika virus infection. PLoS Pathogens. 19(3). e1010843–e1010843. 12 indexed citations

Rosli, Sarah, Christopher M. Harpur, Maggie Lam, et al.. (2023). Gasdermin D promotes hyperinflammation and immunopathology during severe influenza A virus infection. Cell Death and Disease. 14(11). 727–727. 27 indexed citations

Rosli, Sarah, et al.. (2021). Interleukin‐1β exacerbates disease and is a potential therapeutic target to reduce pulmonary inflammation during severe influenza A virus infection. Immunology and Cell Biology. 99(7). 737–748. 33 indexed citations

Qin, Cheng Xue, Sarah Rosli, Minh Deo, et al.. (2019). Cardioprotective Actions of the Annexin-A1 N-Terminal Peptide, Ac2-26, Against Myocardial Infarction. Frontiers in Pharmacology. 10. 269–269. 31 indexed citations

Jelinic, Maria, Chen Huei Leo, Hooi Hooi Ng, et al.. (2019). Annexin‐A1 deficiency exacerbates pathological remodelling of the mesenteric vasculature in insulin‐resistant, but not insulin‐deficient, mice. British Journal of Pharmacology. 177(7). 1677–1691. 17 indexed citations

Dowling, Jennifer K., Michelle D. Tate, Sarah Rosli, et al.. (2019). The Single Nucleotide Polymorphism Mal-D96N Mice Provide New Insights into Functionality of Mal in TLR Immune Responses. The Journal of Immunology. 202(8). 2384–2396. 2 indexed citations

10.

Rosli, Sarah, et al.. (2019). Repurposing drugs targeting the P2X7 receptor to limit hyperinflammation and disease during influenza virus infection. British Journal of Pharmacology. 176(19). 3834–3844. 58 indexed citations

11.

Ruwanpura, Saleela M., Sarah Rosli, & Michelle D. Tate. (2018). Lung Diseases. PubMed. 108. 61–84. 2 indexed citations

12.

Qin, Cheng Xue, Lauren T. May, Nga Cao, et al.. (2017). Small-molecule-biased formyl peptide receptor agonist compound 17b protects against myocardial ischaemia-reperfusion injury in mice. Nature Communications. 8(1). 14232–14232. 107 indexed citations

13.

Prakoso, Darnel, Miles J. De Blasio, Cheng Xue Qin, et al.. (2017). Phosphoinositide 3-kinase (p110α) gene delivery limits diabetes-induced cardiac NADPH oxidase and cardiomyopathy in a mouse model with established diastolic dysfunction. Clinical Science. 131(12). 1345–1360. 47 indexed citations

14.

Qin, Cheng Xue, Annas Al‐Sharea, Mitchel Tate, et al.. (2017). Endogenous Annexin-A1 Regulates Haematopoietic Stem Cell Mobilisation and Inflammatory Response Post Myocardial Infarction in Mice In Vivo. Scientific Reports. 7(1). 16615–16615. 32 indexed citations

15.

Blasio, Miles J. De, Darnel Prakoso, Cheng Xue Qin, et al.. (2016). Abstract 15267: Cardiac-Specific Insulin-Like Growth Factor-1 Receptor (IGF-1R) Expression Targets Maladaptive Hexosamine Biosynthesis and O-Linked GlcNAc Modification of Sarco/Endoplasmic Reticulum Ca2+-ATPase (SERCA2a) in Diabetic Myocardium. Circulation. 134. 1 indexed citations

16.

Blasio, Miles J. De, Karina Huynh, Cheng Xue Qin, et al.. (2015). Therapeutic targeting of oxidative stress with coenzyme Q10 counteracts exaggerated diabetic cardiomyopathy in a mouse model of diabetes with diminished PI3K(p110α) signaling. Free Radical Biology and Medicine. 87. 137–147. 69 indexed citations

17.

Cao, Nga, Sarah Rosli, Helen Kiriazis, et al.. (2015). Chronic Administration of the Nitroxyl Donor 1-Nitrosocyclo Hexyl Acetate Limits Left Ventricular Diastolic Dysfunction in a Mouse Model of Diabetes Mellitus In Vivo. Circulation Heart Failure. 8(3). 572–581. 20 indexed citations

18.

Tesch, Greg H., et al.. (2015). Earlier onset of diabesity‐Induced adverse cardiac remodeling in female compared to male mice. Obesity. 23(6). 1166–1177. 20 indexed citations

19.

Ritchie, Rebecca H., Nga Cao, Sarah Rosli, et al.. (2014). Abstract 16485: The Nitroxyl Donor 1-Nitrosocyclohexyl Acetate Limits Cardiac Superoxide Upregulation and Diastolic Dysfunction in a Mouse Model of Diabetic Cardiomyopathy. Circulation. 130(suppl_2). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact